Ross Muken
Stock Analyst at Evercore ISI Group
(2.03)
# 2,862
Out of 4,854 analysts
40
Total ratings
57.14%
Success rate
0.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ross Muken
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: In-Line | $190 → $225 | $141.20 | +59.35% | 6 | Nov 7, 2024 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $360 → $350 | $134.82 | +159.61% | 7 | Oct 8, 2024 | |
| HSIC Henry Schein | Maintains: In-Line | $70 → $74 | $70.41 | +5.10% | 8 | Oct 8, 2024 | |
| A Agilent Technologies | Maintains: In-Line | $126 → $130 | $113.94 | +14.10% | 11 | Jul 2, 2024 | |
| QGEN Qiagen | Downgrades: In-Line | n/a | $45.56 | - | 2 | Jul 16, 2019 | |
| CAH Cardinal Health | Initiates: In-Line | $67 | $154.12 | -56.53% | 2 | Jan 5, 2018 | |
| ILMN Illumina | Initiates: Outperform | $250 | $82.25 | +203.95% | 2 | Jan 4, 2018 | |
| TMO Thermo Fisher Scientific | Initiates: Outperform | $220 | $398.36 | -44.77% | 1 | Jan 4, 2018 | |
| MBLY Mobileye Global | Downgrades: In-Line | n/a | $16.50 | - | 1 | Mar 13, 2017 |
Charles River Laboratories International
Nov 7, 2024
Maintains: In-Line
Price Target: $190 → $225
Current: $141.20
Upside: +59.35%
ICON Public Limited Company
Oct 8, 2024
Maintains: Outperform
Price Target: $360 → $350
Current: $134.82
Upside: +159.61%
Henry Schein
Oct 8, 2024
Maintains: In-Line
Price Target: $70 → $74
Current: $70.41
Upside: +5.10%
Agilent Technologies
Jul 2, 2024
Maintains: In-Line
Price Target: $126 → $130
Current: $113.94
Upside: +14.10%
Qiagen
Jul 16, 2019
Downgrades: In-Line
Price Target: n/a
Current: $45.56
Upside: -
Cardinal Health
Jan 5, 2018
Initiates: In-Line
Price Target: $67
Current: $154.12
Upside: -56.53%
Illumina
Jan 4, 2018
Initiates: Outperform
Price Target: $250
Current: $82.25
Upside: +203.95%
Thermo Fisher Scientific
Jan 4, 2018
Initiates: Outperform
Price Target: $220
Current: $398.36
Upside: -44.77%
Mobileye Global
Mar 13, 2017
Downgrades: In-Line
Price Target: n/a
Current: $16.50
Upside: -